The $11.30 level comes directly from averaging three current analyst targets. JPMorgan’s Peter Zhang reduced the target to $9.70 from $10.50 in September 2026 while retaining a Neutral rating after an earlier downgrade. UBS has kept a Neutral view with a target near $9.20, adjusting downward during 2026 amid legal and provisioning issues. Citi remains the most optimistic with a Buy rating and $14.90 target set in March 2026, pointing to an expected dividend yield around 12% for the year.
Averaging these three numbers produces $11.27, which rounds to the $11.30 reference point. The spread from roughly $9.20 to $14.90 shows the Street remains divided on NOAH. Other aggregators report varying averages depending on the targets included, so any single consensus number should be approached with caution. No target guarantees future trading levels.
As of late October 2026, NOAH shares traded near $6.75, well below early 2026 levels above $11 and close to the 52-week low around $6.57. Market capitalization stands at approximately $460 million, with a trailing P/E in the single digits and a forward dividend yield near 10%.
Reaching $11.30 from $6.75 would require about 67% appreciation, essentially reversing most of the 2026 decline. Achieving that would likely need stabilizing domestic revenue, continued overseas expansion, and a re-rating of the compressed valuation. This would represent a meaningful shift in investor sentiment rather than a modest adjustment.
From what I see, several elements offer potential support. The company reported non-GAAP net profit growth of about 11% year over year for 2025 and distributed essentially all of it through regular and special dividends, backing a yield in the low double digits. The balance sheet shows a net-cash position that provides flexibility. Overseas investment-product revenue has grown rapidly, and management continues to expand international client efforts. A compressed valuation could allow even modest earnings stability to translate into a higher share price.
Challenges remain significant. Fourth-quarter 2025 profit declined sharply due to fair-value losses from equity affiliates and litigation-related expenses, and JPMorgan has noted that 2026 revenue growth faces headwinds. Domestic wealth-management demand remains linked to China’s property and capital-market cycles, which continue to carry uncertainty. Regulatory and legal overhangs persist, and the ongoing decline toward the 52-week low reflects subdued sentiment that will take time to improve. A high dividend yield by itself has not reversed the trend so far.
NOAH trades just above its 52-week low near $6.57, making the $6.50–$6.60 zone an important support area. On the upside, resistance appears near $8.80, followed by the $10 level that would need to be cleared before the $11.30 target becomes realistic. The 52-week high around $12.45 serves as a longer-term reference. The current structure, with the stock testing lows, suggests that sustained buying would be required to shift the trend.
Analyst targets generally reflect a roughly 12-month horizon. Investors should focus on the next earnings release and guidance, any revisions from analysts including updates to Citi’s more bullish stance, dividend announcements, and macroeconomic or policy signals from China that influence wealth-management demand. The next scheduled earnings were expected in late November 2026, which could serve as an important catalyst.
I also checked recent activity using Tickeron’s AI Daily Buy/Sell Signals to see how shifting technical conditions align with the broader picture for NOAH.
In my own process, I regularly use Tickeron’s AI Daily Buy/Sell Signals to scan market conditions across thousands of stocks and ETFs. The system generates Buy, Sell, or Hold signals based on technical behavior and AI analysis, which helps surface potential opportunities and monitor positions like NOAH more efficiently amid earnings and China-related developments. This approach complements traditional research without replacing it.
Can NOAH reach $11.30? The level is simply the arithmetic average of three recent analyst targets and sits roughly 67% above the current price, requiring a substantial turnaround in revenue and sentiment. Supporting factors include the double-digit dividend yield, net-cash balance sheet, and overseas growth, while obstacles center on domestic revenue weakness, legal matters, and China macro risks. Analyst opinions diverge sharply, so the target reflects a midpoint of disagreement rather than broad agreement. Outcomes will likely depend on upcoming earnings, guidance, and signs of domestic stabilization. No result is assured, and the target functions as a research reference rather than a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
NOAH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for NOAH entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. NOAH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.050) is normal, around the industry mean (2.410). P/E Ratio (0.792) is within average values for comparable stocks, (-3.016). NOAH's Projected Growth (PEG Ratio) (6.620) is very high in comparison to the industry average of (1.319). Dividend Yield (0.821) settles around the average of (0.272) among similar stocks. P/S Ratio (1.439) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOAH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment advisory and wealth management services
Industry InvestmentManagers